Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/03/1991 | CA1288423C Pharmaceutical composition containing a carrageenan complex |
09/03/1991 | CA1288354C Guar flour |
09/03/1991 | CA1288353C Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations |
09/03/1991 | CA1288352C2 Indole-2-alkanoic acids |
09/03/1991 | CA1288350C Controlled release dihydrocodeine composition |
09/03/1991 | CA1288349C Analgesic tablet of aspirin, acetaminophen and caffeine containinglow-substituted hydroxypropyl cellulose |
09/03/1991 | CA1288348C Product and process for promoting the regression of atherosclerosis in animals |
09/03/1991 | CA1288347C Pharmaceutical compositions for the treatment of intermittent claudication |
09/03/1991 | CA1288346C Use of n-acetylglucosamine for the therapy of degenerative joint disease and related diseases |
09/03/1991 | CA1288345C Antibacterial composition containing primicin |
09/03/1991 | CA1288332C Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment |
09/02/1991 | WO1991013903A1 Heterocyclic steroid compounds |
09/02/1991 | CA2077680A1 Heterocyclic steroid compounds |
09/02/1991 | CA2037414A1 13-ether-substituted milbemycin derivatives |
09/02/1991 | CA2037300A1 Hydroxymacrolide derivatives having immunosuppressive activity |
09/01/1991 | CA2018388A1 Therapeutic agent for tinea |
08/31/1991 | CA2011107A1 Lactam derivatives |
08/29/1991 | WO1991012800A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
08/29/1991 | WO1991012798A1 Process and composition for the treating of injuries caused by the radiation of heat and light |
08/29/1991 | CA2050285A1 Process and composition for the treating of injuries caused by the radiation of heat and light |
08/29/1991 | CA2037252A1 Pharmaceutical composition |
08/29/1991 | CA2037239A1 (s)-norfluoxetine |
08/29/1991 | CA2037200A1 Water soluble salts of purpuromycin and pharmaceutical formulations thereof |
08/29/1991 | CA2037178A1 Deprenyl/l-dopa/carbidopa pharmaceutical composition |
08/29/1991 | CA2037088A1 Prostaglandins for inhibiting cartilage damage |
08/29/1991 | CA2037084A1 Propanamins, their pharmacological properties and their application to therapeutic ends, notably antidiarrheics |
08/28/1991 | WO1991013062A2 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
08/28/1991 | EP0444000A2 Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
08/28/1991 | EP0443996A1 Esters of (R)(-)-carnitine and acyl (R)(-)-carnitines with beta-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration, liver proteolysis and for the treatment of coma |
08/28/1991 | EP0443983A1 Acyl compounds |
08/28/1991 | EP0443957A2 New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them |
08/28/1991 | EP0443956A1 Lactic acid acylates, their salts, process of preparation and compositions containing them |
08/28/1991 | EP0443918A1 Derivatives of 20,21-dinoreburnamenine, process for their preparation and intermediates, their use as medicines and compositions containing them |
08/28/1991 | EP0443891A1 Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation |
08/28/1991 | EP0443883A1 Carbapenem derivatives having antibiotic activity, their preparation and their use |
08/28/1991 | EP0443848A1 Novel anti-ulcer substance |
08/28/1991 | EP0443789A1 Use of refined pyrodextrin hydrolysate |
08/28/1991 | EP0443788A1 Food composite for performing function of large bowel regulation |
08/28/1991 | EP0443743A2 Coated vitamin C preparation for animal feed, production and use thereof |
08/28/1991 | EP0443710A1 Benzoquinone antiallergy and antiinflammatory agents |
08/28/1991 | EP0443654A2 Antibiotic agent |
08/28/1991 | EP0443635A1 Method for producing l-sesamin using plant cell cultures |
08/28/1991 | EP0443569A2 Diamine derivatives and their use in oncology |
08/28/1991 | EP0443560A2 HIV protease inhibitors |
08/28/1991 | EP0443518A2 Pharmaceutical containing episialo complex carbohydrate |
08/28/1991 | EP0443474A2 1-Phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents |
08/28/1991 | EP0443471A1 2'-Deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
08/28/1991 | EP0443413A1 Pharmaceutical composition having depigmentating and antiphotoaging activity |
08/28/1991 | EP0443312A2 2,4,8-trisubstituted-3H-6H-1,4,5a,8a-tetraazaacenaphthylene-3,5-(4H)-diones |
08/28/1991 | EP0443198A2 Diterpenes with immunomodulatory activity |
08/28/1991 | EP0443197A2 Oxazolidinones |
08/28/1991 | EP0443090A2 Agent for preventing infection with methicillin-resistant staphylococcus |
08/28/1991 | EP0443028A1 Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer |
08/28/1991 | EP0443027A1 Drug composition |
08/28/1991 | EP0443021A1 Novel use of vitamin d compounds to inhibit replication of the aids virus |
08/28/1991 | EP0442878A1 Derivatives of tryptophan as cck antagonists |
08/28/1991 | EP0428668A4 Water-soluble vitamin a preparations for application to the skin |
08/28/1991 | EP0408749A4 Derivatives of 3,18-dihydroxy-9,13-epoxylabdane, method of obtaining them and a hemostatic pharmaceutical preparation based thereon |
08/28/1991 | EP0228448B1 Use of biologically active copolymers for the manufacture of a medicament for stimulating the growth of an animal |
08/28/1991 | EP0113373B1 Sustained release quinidine dosage form |
08/28/1991 | EP0109439B1 Amino acid solutions for parenteral nutrition and methods of formulation and use |
08/28/1991 | CN1054071A Orally active renin inhibitors |
08/28/1991 | CN1054066A Improvements in and relating to leukotriene antagonists |
08/28/1991 | CN1054065A Thiazine or oxazine derivatives and preparation thereof |
08/28/1991 | CN1013687B Tricycle compounds, a process for their production and a pharmaceutical composition containing the same |
08/28/1991 | CN1013676B 6-thioxanthine derivatives |
08/28/1991 | CN1013674B Process for the preparation of n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propion-amidine |
08/28/1991 | CN1013673B Indenopyrimidine derivatives |
08/28/1991 | CN1013672B Process for the praparation of 2-amino-5-hydroxy-4-mathylpyrimidine derivatives |
08/28/1991 | CA2053256A1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
08/28/1991 | CA2037081A1 Carboxylic acid derivatives |
08/28/1991 | CA2036978A1 Aminomethylpiperidine derivatives; process for preparing the same and pharmaceutical compositions containing them |
08/28/1991 | CA2036975A1 Benzofurans |
08/27/1991 | WO1991013061A1 4(1h)quinolone derivatives |
08/27/1991 | WO1991013054A1 Cycloalkyl-substituted glutaramide antihypertensive agents |
08/27/1991 | US5043482 New derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and cosmetic and pharmaceutical compositions containing them |
08/27/1991 | US5043457 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents |
08/27/1991 | US5043456 6-oxa and thiabicyclo [3.1.0.] compounds |
08/27/1991 | US5043451 Bicyclo (2.2.1.) hept-exo-2-yl and bicyclo (2.2.2.) oct-endo-2-yl compounds |
08/27/1991 | US5043450 8-alkoxyquinolonecarboxylic acid and salts thereof |
08/27/1991 | US5043441 Compositions comprising 1-substituted azacycloalkanes |
08/27/1991 | US5043440 Oxidation process for preparing 4-acyloxy azetidinones in a two-phase system |
08/27/1991 | US5043437 5'phosphonates of 3'-azido-2',3'dideoxynucleosides |
08/27/1991 | US5043416 Method of inhibiting virus |
08/27/1991 | US5043358 Gastroprotective process |
08/27/1991 | US5043357 Virucidal agent having broad-spectrum activity |
08/27/1991 | US5043356 Composition and method for rejuvenating skin using vitamin A propionate |
08/27/1991 | US5043355 Use of L-carnitine derivatives in the therapeutical treatment of peripheral neuropathies |
08/27/1991 | US5043354 Pharmaceutically useful 5-hydroxy-2,3-dihydro-benzofurans and 5-hydroxy-benzofurans |
08/27/1991 | US5043353 A80789 polyether antibiotic |
08/27/1991 | US5043352 Chroman derivatives for the treatment of depressive states |
08/27/1991 | US5043347 Indanes and analgesic compositions and methods thereof |
08/27/1991 | US5043345 Cognition activators; alzheimer's disease |
08/27/1991 | US5043344 Unsaturated N-benzopyranyllactams |
08/27/1991 | US5043343 Certain 5-substituted-1-aza-bicyclo[3.3.3]heptanes and their pharmaceutical compositions and methods |
08/27/1991 | US5043342 Oxadiazolyl bicycloheptanes for dementia treatment |
08/27/1991 | US5043341 N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides |
08/27/1991 | US5043339 Oral delivery for lower dosage; herpes, cytomegalo viruses |
08/27/1991 | US5043335 Enzyme inhibitors; cardiovascular and central nervous system disorders |
08/27/1991 | US5043334 Cephalosporin antibiotics |